IMXCF (IMAX China Holding) Research & Development: $0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IMXCF IMAX China Holding Inc IMXCF
66 GF Score
Price $1.05
GF Value $0.85
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is IMAX China Holding Research & Development?

IMAX China Holding IMXCF 66 Research & Development is $0.00 Mil as of Jun. 2026. GuruFocus rates IMXCF with a GF Score™ of 66/100 and a GF Value™ of $0.85 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. IMAX China Holding's Research & Development for the six months ended in Jun. 2026 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was $0.00 Mil.

IMAX China Holding  (OTCPK:IMXCF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

IMAX China Holding Research & Development Related Terms

IMAX China Holding Research & Development Historical Data

* Premium members only.

The historical data trend for IMAX China Holding's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMAX China Holding Research & Development Chart

IMAX China Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IMAX China Holding Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
IMXCF
66GF Score
IMAX China Holding Inc IMXCF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IMAX China Holding Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
IMAX China Holding (IMXCF) has a Research & Development of $0.00 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on IMAX China Holding and its competitors.
Is IMAX China Holding's Research & Development too high?
IMAX China Holding's current Research & Development is $0.00 Mil. Overall, IMAX China Holding has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IMAX China Holding's Research & Development compare to NFLX and DIS?
IMAX China Holding's Research & Development of $0.00 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Media - Diversified company?
A good Research & Development depends on the Media - Diversified industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on IMAX China Holding and its competitors. IMAX China Holding's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMAX China Holding stock overvalued right now?
Based on GuruFocus' analysis, IMAX China Holding (IMXCF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.85, compared to a current price of $1.05 — trading 24% above its estimated fair value. The current Research & Development is $0.00 Mil. IMAX China Holding's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For IMAX China Holding (IMXCF), the current Research & Development is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IMAX China Holding (IMXCF) Overvalued in 2026?

Based on GuruFocus' analysis, IMAX China Holding stock appears to be overvalued. The current stock price of $1.05 is trading 24% above its estimated GF Value™ of $0.85. GuruFocus considers IMAX China Holding to be Modestly Overvalued.

Key valuation signals for IMXCF:

  • Research & Development: $0.00 Mil
  • GF Value™: $0.85 vs. price of $1.05 (24% above fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the IMXCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IMAX China Holding Business Description

Other Exchanges 01970:Hong KongIMK:Germany
Address Unit 1201-1208, No. 168 Hubin Road, Infinitus Tower, 12th Floor, Huangpu District, Shanghai, CHN
IMAX China Holding Inc is an investment holding company that operates in the Entertainment industry in China. The Group has two reportable segments: Content Solutions, which principally includes content enhancement and distribution, and Technology Products and Services, which principally includes the sales, lease, and maintenance of IMAX Systems. The Group's activities that do not meet the criteria for a reportable segment are reported within all Others. The company operates in Mainland China, Hong Kong, Taiwan, and Macau, with the majority of revenue from Mainland China.
66GF Score

Get the complete analysis for IMXCF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.05
Price
$0.85
GF Value